BlackRock Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $31.9M | Buy |
384,886
+25,913
| +7% | +$2.15M | 0.03% | 380 |
|
|
2016
Q3 | $33.2M | Buy |
358,973
+2,312
| +0.6% | +$214K | 0.03% | 372 |
|
|
2016
Q2 | $27.7M | Sell |
356,661
-134,298
| -27% | -$10.4M | 0.03% | 420 |
|
|
2016
Q1 | $40.5M | Buy |
490,959
+18,995
| +4% | +$1.57M | 0.04% | 355 |
|
|
2015
Q4 | $49.4M | Buy |
471,964
+56,337
| +14% | +$5.9M | 0.05% | 320 |
|
|
2015
Q3 | $43.8M | Sell |
415,627
-125,722
| -23% | -$13.2M | 0.05% | 319 |
|
|
2015
Q2 | $74M | Sell |
541,349
-264,747
| -33% | -$36.2M | 0.08% | 246 |
|
|
2015
Q1 | $100M | Sell |
806,096
-249,623
| -24% | -$31.1M | 0.1% | 210 |
|
|
2014
Q4 | $95.4M | Sell |
1,055,719
-171,041
| -14% | -$15.5M | 0.1% | 220 |
|
|
2014
Q3 | $88.5M | Buy |
1,226,760
+168,148
| +16% | +$12.1M | 0.09% | 231 |
|
|
2014
Q2 | $65.9M | Sell |
1,058,612
-155,936
| -13% | -$9.7M | 0.06% | 286 |
|
|
2014
Q1 | $82.8M | Buy |
1,214,548
+315,926
| +35% | +$21.5M | 0.08% | 247 |
|
|
2013
Q4 | $63.2M | Sell |
898,622
-24,919
| -3% | -$1.75M | 0.06% | 296 |
|
|
2013
Q3 | $66.7M | Buy |
923,541
+432,235
| +88% | +$31.2M | 0.07% | 280 |
|
|
2013
Q2 | $27.4M | Buy |
+491,306
| New | +$27.4M | 0.03% | 439 |
|